PARADIGM BIOPHARMACEUTICALS LIMITED.. - Announcements

0.79%

31.3¢

Market Cap $124.1M

Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight

PAR - close to a cure for osteoarthritis?

Announcements

Filter Results

All Price Sensitive Only

PAR	Investor Webinar Presentation		31/07/25	6.67MB	Share
PAR	June 2025 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/07/25	416.9KB	Share
PAR	Paradigm Investor Webinar		24/07/25	72.66KB	Share
PAR	Application for quotation of securities - PAR		22/07/25	15.51KB	Share
PAR	Notice under Section 708A		07/07/25	267.78KB	Share
PAR	Notification regarding unquoted securities - PAR		07/07/25	19.31KB	Share
PAR	Notice under Section 708A		02/07/25	112.83KB	Share
PAR	Application for quotation of securities - PAR		02/07/25	15.6KB	Share
PAR	Proposed issue of securities - PAR		01/07/25	18.57KB	Share
PAR	Proposed issue of securities - PAR		01/07/25	14.91KB	Share
PAR	Paradigm Secures US$27M to Advance Phase 3 OA Trial	PRICE SENSITIVE	01/07/25	155.34KB	Share
PAR	US Sites Activated and Patients Consented		30/06/25	116.6KB	Share
PAR	Paradigm Strengthens OA Pipeline with Strategic Acquisition	PRICE SENSITIVE	26/06/25	329.26KB	Share
PAR	Phase 3 Knee OA Trial Begins, Site Live, Patient Consented		03/06/25	145.17KB	Share
PAR	Results of Meeting		29/05/25	97.35KB	Share
PAR	PAR Receives US Ethics Approval for Phase 3	PRICE SENSITIVE	15/05/25	153.91KB	Share
PAR	Notice of General Meeting/Proxy Form		29/04/25	352.85KB	Share
PAR	March 2025 Quarterly Activities Report & Appendix 4C	PRICE SENSITIVE	29/04/25	1.05MB	Share
PAR	Paradigm to present at NWR Healthcare Conference		18/03/25	60.45KB	Share
PAR	Application for quotation of securities - PAR		14/03/25	15.47KB	Share
PAR	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
PAR	Appendix 4D and Half Year Report	PRICE SENSITIVE	28/02/25	2.89MB	Share
PAR	Paradigm Secures Ethics Approval for Phase 3 Trial	PRICE SENSITIVE	24/02/25	147.26KB	Share
PAR	Change of Director's Interest Notice		14/02/25	190.66KB	Share
PAR	Change of Director's Interest Notice		14/02/25	5.85KB	Share
PAR	Listing of Options - Top 20 Holders and Distribution Reports		11/02/25	84.06KB	Share
PAR	Application for quotation of securities - PAR		11/02/25	15.41KB	Share
PAR	Proposed issue of securities - PAR		03/02/25	16.72KB	Share
PAR	Cancel - Proposed issue of securities - PAR		03/02/25	19.82KB	Share
PAR	Proposed issue of securities - PAR		31/01/25	19.99KB	Share
PAR	Loyalty and Piggyback Options Program	PRICE SENSITIVE	31/01/25	399.14KB	Share
PAR	PAR Selects Advanced Clinical as CRO for Phase 3	PRICE SENSITIVE	31/01/25	356.25KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/01/25	317.89KB	Share
PAR	Application for quotation of securities - PAR		29/01/25	14.08KB	Share
PAR	Paradigm Receives $6.3m R&D Tax Refund	PRICE SENSITIVE	24/01/25	67.64KB	Share
PAR	Notice of release of escrowed securities		16/01/25	173KB	Share
PAR	Change of Director's Interest Notice		30/12/24	49.74KB	Share
PAR	Notification regarding unquoted securities - PAR		20/12/24	16.23KB	Share
PAR	Cleansing Notice		13/12/24	132.72KB	Share
PAR	Application for quotation of securities - PAR		13/12/24	15.46KB	Share
PAR	PAR Capital Raising Presentation	PRICE SENSITIVE	09/12/24	9.28MB	Share
PAR	Proposed issue of securities - PAR		09/12/24	15.33KB	Share
PAR	Successful Completion of $16M Placement for Phase 3	PRICE SENSITIVE	09/12/24	416.01KB	Share
PAR	Change of Director's Interest Notice		05/12/24	183.07KB	Share
PAR	Change of Director's Interest Notice		05/12/24	5.71KB	Share
PAR	Trading Halt	PRICE SENSITIVE	05/12/24	285.81KB	Share
PAR	Appendix 3H - Notification of cessation of securities		05/12/24	223.34KB	Share
PAR	Appendix 2A		04/12/24	333.5KB	Share
PAR	Paradigm to Proceed with Phase 3 Knee OA Trial	PRICE SENSITIVE	28/11/24	348.47KB	Share
PAR	Response to ASX Price Query	PRICE SENSITIVE	25/11/24	354.29KB	Share
PAR	Change of Director's Interest Notice		21/11/24	90.35KB	Share
PAR	Notification of cessation of securities - PAR		21/11/24	12.69KB	Share
PAR	Final Director's Interest Notice		20/11/24	150.2KB	Share
PAR	Dr. Skerrett Steps Down from Board Following AGM		20/11/24	338.68KB	Share
PAR	Results of Meeting		19/11/24	279.93KB	Share
PAR	2024 Chairman Address and AGM Presentation	PRICE SENSITIVE	19/11/24	15.42MB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/24	322.75KB	Share
PAR	Phase 3 Protocol Submission to US FDA	PRICE SENSITIVE	31/10/24	154.85KB	Share
PAR	Proposed issue of securities - PAR		24/10/24	16.89KB	Share
PAR	Change of Director's Interest Notice		23/10/24	169.23KB	Share
PAR	Change of Director's Interest Notice		23/10/24	178.58KB	Share
PAR	Notification of cessation of securities - PAR		22/10/24	13.38KB	Share
PAR	Paradigm Investor Update	PRICE SENSITIVE	21/10/24	150.6KB	Share
PAR	Notice of Annual General Meeting/Proxy Form		18/10/24	623.74KB	Share
PAR	Change of Director's Interest Notice		16/10/24	179.36KB	Share
PAR	Change of Director's Interest Notice		16/10/24	203.79KB	Share
PAR	Ceasing to be a substantial holder		26/09/24	8.48MB	Share
PAR	Date of AGM & Closing Date for Director Nominations		20/09/24	113.44KB	Share
PAR	PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3	PRICE SENSITIVE	18/09/24	344.91KB	Share
PAR	Application for quotation of securities - PAR		10/09/24	14.13KB	Share
PAR	Notice of release of escrowed securities		03/09/24	250.8KB	Share
PAR	Appendix 4G and Corporate Governance Statement		30/08/24	446.5KB	Share
PAR	Appendix 4E and 2024 Annual Report	PRICE SENSITIVE	30/08/24	3.3MB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/24	520.04KB	Share
PAR	Change in substantial holding		22/05/24	8.51MB	Share
PAR	Application for quotation of securities - PAR		20/05/24	15.51KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	325KB	Share
PAR	Notification of cessation of securities - PAR		26/04/24	13.22KB	Share
PAR	Type D Response Submitted and Received by the US FDA	PRICE SENSITIVE	19/04/24	157.42KB	Share
PAR	Notification of cessation of securities - PAR		05/04/24	13.23KB	Share
PAR	PAR to present at NWR Healthcare Conference		20/03/24	90.2KB	Share
PAR	Change of Director's Interest Notice		08/03/24	169.7KB	Share
PAR	Change of Director's Interest Notice		08/03/24	180.97KB	Share
PAR	Final Director's Interest Notice		06/03/24	150.9KB	Share
PAR	Initial Director's Interest Notice		04/03/24	157.18KB	Share
PAR	Paradigm Board Changes		04/03/24	135.46KB	Share
PAR	Notification regarding unquoted securities - PAR		29/02/24	16.25KB	Share
PAR	PAR Employee Performance Rights Plan Issue		29/02/24	112.65KB	Share
PAR	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/24	3.77MB	Share
PAR	Notification regarding unquoted securities - PAR		13/02/24	17.5KB	Share
PAR	Proposed issue of securities - PAR		12/02/24	23.96KB	Share
PAR	PAR Appoints Business Development Consultant		09/02/24	143.13KB	Share
PAR	Primary Endpoint Achieved in Phase 2 MPS VI Trial	PRICE SENSITIVE	09/02/24	387.82KB	Share
PAR	Paradigm Receives $7.36m R&D Tax Incentive Refund	PRICE SENSITIVE	07/02/24	61KB	Share
PAR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	350.17KB	Share
PAR	Notification of cessation of securities - PAR		30/01/24	21.97KB	Share
PAR	Application for quotation of securities - PAR		30/01/24	24.1KB	Share
PAR	PAR Selected for Major OA Conference Presentations		30/01/24	127.74KB	Share
PAR	Notice of release of escrowed securities		15/01/24	299.38KB	Share
PAR	Change in substantial holding		06/12/23	225.29KB	Share

PAR Investor Webinar Presentation
31/07/25		6.67MB	Share
PAR June 2025 Quarterly Activities Report & Appendix 4C
29/07/25	PRICE SENSITIVE	416.9KB	Share
PAR Paradigm Investor Webinar
24/07/25		72.66KB	Share
PAR Application for quotation of securities - PAR
22/07/25		15.51KB	Share
PAR Notice under Section 708A
07/07/25		267.78KB	Share
PAR Notification regarding unquoted securities - PAR
07/07/25		19.31KB	Share
PAR Notice under Section 708A
02/07/25		112.83KB	Share
PAR Application for quotation of securities - PAR
02/07/25		15.6KB	Share
PAR Proposed issue of securities - PAR
01/07/25		18.57KB	Share
PAR Proposed issue of securities - PAR
01/07/25		14.91KB	Share
PAR Paradigm Secures US$27M to Advance Phase 3 OA Trial
01/07/25	PRICE SENSITIVE	155.34KB	Share
PAR US Sites Activated and Patients Consented
30/06/25		116.6KB	Share
PAR Paradigm Strengthens OA Pipeline with Strategic Acquisition
26/06/25	PRICE SENSITIVE	329.26KB	Share
PAR Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
03/06/25		145.17KB	Share
PAR Results of Meeting
29/05/25		97.35KB	Share
PAR PAR Receives US Ethics Approval for Phase 3
15/05/25	PRICE SENSITIVE	153.91KB	Share
PAR Notice of General Meeting/Proxy Form
29/04/25		352.85KB	Share
PAR March 2025 Quarterly Activities Report & Appendix 4C
29/04/25	PRICE SENSITIVE	1.05MB	Share
PAR Paradigm to present at NWR Healthcare Conference
18/03/25		60.45KB	Share
PAR Application for quotation of securities - PAR
14/03/25		15.47KB	Share
PAR S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
PAR Appendix 4D and Half Year Report
28/02/25	PRICE SENSITIVE	2.89MB	Share
PAR Paradigm Secures Ethics Approval for Phase 3 Trial
24/02/25	PRICE SENSITIVE	147.26KB	Share
PAR Change of Director's Interest Notice
14/02/25		190.66KB	Share
PAR Change of Director's Interest Notice
14/02/25		5.85KB	Share
PAR Listing of Options - Top 20 Holders and Distribution Reports
11/02/25		84.06KB	Share
PAR Application for quotation of securities - PAR
11/02/25		15.41KB	Share
PAR Proposed issue of securities - PAR
03/02/25		16.72KB	Share
PAR Cancel - Proposed issue of securities - PAR
03/02/25		19.82KB	Share
PAR Proposed issue of securities - PAR
31/01/25		19.99KB	Share
PAR Loyalty and Piggyback Options Program
31/01/25	PRICE SENSITIVE	399.14KB	Share
PAR PAR Selects Advanced Clinical as CRO for Phase 3
31/01/25	PRICE SENSITIVE	356.25KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
30/01/25	PRICE SENSITIVE	317.89KB	Share
PAR Application for quotation of securities - PAR
29/01/25		14.08KB	Share
PAR Paradigm Receives $6.3m R&D Tax Refund
24/01/25	PRICE SENSITIVE	67.64KB	Share
PAR Notice of release of escrowed securities
16/01/25		173KB	Share
PAR Change of Director's Interest Notice
30/12/24		49.74KB	Share
PAR Notification regarding unquoted securities - PAR
20/12/24		16.23KB	Share
PAR Cleansing Notice
13/12/24		132.72KB	Share
PAR Application for quotation of securities - PAR
13/12/24		15.46KB	Share
PAR PAR Capital Raising Presentation
09/12/24	PRICE SENSITIVE	9.28MB	Share
PAR Proposed issue of securities - PAR
09/12/24		15.33KB	Share
PAR Successful Completion of $16M Placement for Phase 3
09/12/24	PRICE SENSITIVE	416.01KB	Share
PAR Change of Director's Interest Notice
05/12/24		183.07KB	Share
PAR Change of Director's Interest Notice
05/12/24		5.71KB	Share
PAR Trading Halt
05/12/24	PRICE SENSITIVE	285.81KB	Share
PAR Appendix 3H - Notification of cessation of securities
05/12/24		223.34KB	Share
PAR Appendix 2A
04/12/24		333.5KB	Share
PAR Paradigm to Proceed with Phase 3 Knee OA Trial
28/11/24	PRICE SENSITIVE	348.47KB	Share
PAR Response to ASX Price Query
25/11/24	PRICE SENSITIVE	354.29KB	Share
PAR Change of Director's Interest Notice
21/11/24		90.35KB	Share
PAR Notification of cessation of securities - PAR
21/11/24		12.69KB	Share
PAR Final Director's Interest Notice
20/11/24		150.2KB	Share
PAR Dr. Skerrett Steps Down from Board Following AGM
20/11/24		338.68KB	Share
PAR Results of Meeting
19/11/24		279.93KB	Share
PAR 2024 Chairman Address and AGM Presentation
19/11/24	PRICE SENSITIVE	15.42MB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/10/24	PRICE SENSITIVE	322.75KB	Share
PAR Phase 3 Protocol Submission to US FDA
31/10/24	PRICE SENSITIVE	154.85KB	Share
PAR Proposed issue of securities - PAR
24/10/24		16.89KB	Share
PAR Change of Director's Interest Notice
23/10/24		169.23KB	Share
PAR Change of Director's Interest Notice
23/10/24		178.58KB	Share
PAR Notification of cessation of securities - PAR
22/10/24		13.38KB	Share
PAR Paradigm Investor Update
21/10/24	PRICE SENSITIVE	150.6KB	Share
PAR Notice of Annual General Meeting/Proxy Form
18/10/24		623.74KB	Share
PAR Change of Director's Interest Notice
16/10/24		179.36KB	Share
PAR Change of Director's Interest Notice
16/10/24		203.79KB	Share
PAR Ceasing to be a substantial holder
26/09/24		8.48MB	Share
PAR Date of AGM & Closing Date for Director Nominations
20/09/24		113.44KB	Share
PAR PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3
18/09/24	PRICE SENSITIVE	344.91KB	Share
PAR Application for quotation of securities - PAR
10/09/24		14.13KB	Share
PAR Notice of release of escrowed securities
03/09/24		250.8KB	Share
PAR Appendix 4G and Corporate Governance Statement
30/08/24		446.5KB	Share
PAR Appendix 4E and 2024 Annual Report
30/08/24	PRICE SENSITIVE	3.3MB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/07/24	PRICE SENSITIVE	520.04KB	Share
PAR Change in substantial holding
22/05/24		8.51MB	Share
PAR Application for quotation of securities - PAR
20/05/24		15.51KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	325KB	Share
PAR Notification of cessation of securities - PAR
26/04/24		13.22KB	Share
PAR Type D Response Submitted and Received by the US FDA
19/04/24	PRICE SENSITIVE	157.42KB	Share
PAR Notification of cessation of securities - PAR
05/04/24		13.23KB	Share
PAR PAR to present at NWR Healthcare Conference
20/03/24		90.2KB	Share
PAR Change of Director's Interest Notice
08/03/24		169.7KB	Share
PAR Change of Director's Interest Notice
08/03/24		180.97KB	Share
PAR Final Director's Interest Notice
06/03/24		150.9KB	Share
PAR Initial Director's Interest Notice
04/03/24		157.18KB	Share
PAR Paradigm Board Changes
04/03/24		135.46KB	Share
PAR Notification regarding unquoted securities - PAR
29/02/24		16.25KB	Share
PAR PAR Employee Performance Rights Plan Issue
29/02/24		112.65KB	Share
PAR Half Yearly Report and Accounts
28/02/24	PRICE SENSITIVE	3.77MB	Share
PAR Notification regarding unquoted securities - PAR
13/02/24		17.5KB	Share
PAR Proposed issue of securities - PAR
12/02/24		23.96KB	Share
PAR PAR Appoints Business Development Consultant
09/02/24		143.13KB	Share
PAR Primary Endpoint Achieved in Phase 2 MPS VI Trial
09/02/24	PRICE SENSITIVE	387.82KB	Share
PAR Paradigm Receives $7.36m R&D Tax Incentive Refund
07/02/24	PRICE SENSITIVE	61KB	Share
PAR Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	350.17KB	Share
PAR Notification of cessation of securities - PAR
30/01/24		21.97KB	Share
PAR Application for quotation of securities - PAR
30/01/24		24.1KB	Share
PAR PAR Selected for Major OA Conference Presentations
30/01/24		127.74KB	Share
PAR Notice of release of escrowed securities
15/01/24		299.38KB	Share
PAR Change in substantial holding
06/12/23		225.29KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 31.3¢		Change -0.003(0.79%)		Mkt cap ! $124.1M

Open	High	Low	Value	Volume
31.0¢	32.0¢	31.0¢	$102.4K	325.9K

Buyers (Bids)

No.	Vol.	Price($)
12	84091	31.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.5¢	27178	6

View Market Depth

No.	Vol.	Price($)
12	84091	0.310
11	139796	0.305
20	222734	0.300
11	114479	0.295
11	234556	0.290

Price($)	Vol.	No.
0.315	27178	6
0.320	22379	8
0.325	11233	5
0.330	46541	4
0.335	21200	4

Last trade - 14.26pm 11/08/2025 (20 minute delay)


Last 31.0¢		Change -0.003 ( 3.13 %)
Open	High	Low	Volume
31.5¢	32.3¢	31.0¢	229240
Last updated 14.40pm 11/08/2025 ?

PAR (ASX) Chart

PARADIGM BIOPHARMACEUTICALS LIMITED.. - Announcements

Corporate Spotlight

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories